AMTB Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
159.7M
+3.8%
153.8M
+2.3%
150.4M
-11.1%
169.2M
-0.5%
170.0M
Cost of Revenue
50.9M
-4.0%
53.1M
+0.7%
52.7M
-7.5%
57.0M
-2.7%
58.6M
Gross Profit
108.8M
+8.0%
100.7M
+3.1%
97.7M
-12.9%
112.2M
+0.7%
111.4M
Operating Expenses
69.1M
+0.3%
68.9M
+2.9%
66.9M
-37.3%
106.8M
+37.2%
77.8M
R&D
—
—
—
—
—
SG&A
27.0M
+3.8%
26.0M
+11.4%
23.3M
-21.7%
29.8M
+5.1%
28.4M
Operating Income
33.5M
+23.6%
27.1M
+18.2%
22.9M
+1103.1%
1.9M
-90.0%
19.0M
EBITDA
33.5M
+23.6%
27.1M
+18.2%
22.9M
+144.3%
9.4M
-50.6%
19.0M
Net Income
25.7M
+22.2%
21.0M
+17.7%
17.9M
+561.7%
2.7M
-81.7%
14.8M
EPS (Basic)
$0.66
+22.2%
$0.54
+22.7%
$0.44
+528.6%
$0.07
-80.0%
$0.35
EPS (Diluted)
$0.65
+22.6%
$0.53
+20.5%
$0.44
+528.6%
$0.07
-80.0%
$0.35
Shares (Diluted)
39.4M
-0.2%
39.5M
-2.5%
40.5M
-1.4%
41.1M
-1.6%
41.8M
Amerant Ban (AMTB) — Financials